Zymeworks Inc. Common Stock Cash Flow Reinvestment Rate
Zymeworks Inc. Common Stock cash flow reinvestment rate. Zymeworks Inc. Common Stock (ZYME) has a Cash Flow Reinvestment Rate of 0.80x as of June 2025, reinvesting $9.63 Million (capex $884.00K plus investments $8.74 Million) from operating cash flow of $12.07 Million. Explore debt repayment capacity of Zymeworks Inc. Common Stock to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Zymeworks Inc. Common Stock (2017–2022)
Cash flow reinvestment rate of Zymeworks Inc. Common Stock from 2017 to 2022. Historical reinvestment intensity for Zymeworks Inc. Common Stock across 3 annual periods. Explore ZYME capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Zymeworks Inc. Common Stock Cash Flow Reinvestment Rate by Year (2017–2022)
Zymeworks Inc. Common Stock cash flow reinvestment rate by year from 2017 to 2022. Year-by-year capital reinvestment analysis for Zymeworks Inc. Common Stock. For the full cash flow conversion analysis, see Zymeworks Inc. Common Stock operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.46x | $66.97 Million | $144.11 Million | $13.12 Million | ▼ -89.7% |
| 2018 | 4.51x | $109.05 Million | $24.18 Million | $3.42 Million | ▼ -96.8% |
| 2017 | 141.04x | $30.89 Million | $219.00K | $3.12 Million | — |